Annals of Translational Medicine · 2021 · 14 citations · 30 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesTumor ProgressionApoptosis In CancerCancer Cell SignalingCancer ProgressionLung CancerMalignant NeoplasmsOncogenic Signaling PathwaysCancer Cell ApoptosisCell Growth RegulationKaplan-meier Confidence IntervalsKaplan-meier Survival EstimatesLung CarcinogenesisLung Tumor PromotionReverse Transcription Polymerase Chain Reaction (Rt-pcr)Western Blotting
BACKGROUND: Non-small cell lung cancer (NSCLC) has a poor prognosis and is the most common cause of cancer-related deaths worldwide. Aminoacylase 1 (ACY1) plays a promoting role in some cancers, but its role in NSCLC is still unclear. METHODS: test and Kaplan-Meier analysis. MTT, flow cytometry, wound healing, and Transwell assays were performed to assess cell growth, apoptosis, migration, invasion, and tumorigenesis under different treatments. Male athymic BALB/C nude mice were used for xenotransplantation experiments. RESULTS: The results showed that ACY1 expression was elevated in NSCLC tissue samples and cells, and high ACY1 expression predicted an advanced clinical process and shorter overall survival in patients with NSCLC. Overexpression of ACY1 significantly increased cell growth, migration, invasion, and tumorigenesis, and reduced cell apoptosis, indicating that ACY1 functions as an oncogene in NSCLC. Moreover, ACY1 decreased phosphatase and tensin homolog (PTEN) expression, increased its ubiquitination, and activated PI3K/AKT signaling. Overexpression of PTEN diminished the effects of ACY1 upregulation on cell tumorigenesis promotion. CONCLUSIONS: This study reveals that ACY1 may promote the progression of NSCLC via activating PI3K/AKT signaling in a PTEN-dependent manner. Our study may provide a better understanding of the pathogenesis and development of NSCLC.
30
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Severin Gloor, Kai Oliver Jensen, Stefan Breitenstein et al. · Case Reports in Gastroenterology · 2017 · 5.4K citations · Full text
Karen Kelly, John Crowley, Paul A. Bunn et al. · Journal of Clinical Oncology · 2001 · 1.1K citations
Medicine, Oncology, Pharmacology +17
The PI3K/AKT/mTOR interactive pathway
Tülin Erşahin, Nurcan Tunçbağ, Rengül Çetin-Atalay · Molecular BioSystems · 2015 · 680 citations · Full text
Medicine, Cancer Biology, Oncology +17
Non–Small Cell Lung Cancer, Version 6.2015
David S. Ettinger, Douglas E. Wood, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2015 · 487 citations